NCT07602049 Cryoablation Plus Camrelizumab for Advanced Soft Tissue Sarcoma Status RECRUITING Phase PHASE2
NCT07593573 the Exploration of MTAP Deletion in Osteosarcoma by Immunohistochemistry Status ACTIVE_NOT_RECRUITING Phase N/A
NCT07516353 my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults Status NOT_YET_RECRUITING Phase NA
NCT07514819 Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma Status NOT_YET_RECRUITING Phase NA
NCT07479732 Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma Status RECRUITING Phase PHASE1/PHASE2
NCT07477457 A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma Status RECRUITING Phase PHASE2
NCT07215728 Machine Learning Applied to EHRs Data of Patients With Sarcoma Status COMPLETED Phase N/A
NCT07142863 Envafolimab Combined With Neoadjuvant Chemotherapy Treat Stage IIb Resectable Osteosarcoma Patients Status NOT_YET_RECRUITING Phase PHASE2
NCT07052383 Safety and Efficacy of DIT309 in Advanced Bone and Soft Tissue Sarcomas Status RECRUITING Phase PHASE1
NCT06935409 Study of HS-20093 Versus Gemcitabine in Combination With Docetaxel in Treatment of Osteosarcoma After Previous Second-line Treatment Failure Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06850506 Exploring the Expression Level of Cadherin 6 Protein (CDH6) in Primary Malignant Bone Tumor Specimens and Its Clinical Application in Prognosis Assessment Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06776198 Precision Therapy Based on Immune Microenvironment by Transcriptome Sequencing of Osteosarcoma, a Prospective, Multi-cohort Exploratory Clinical Study Status NOT_YET_RECRUITING Phase N/A
NCT06726512 Quantitative Margin Assessment Using High-resolution Positron Emission Tomography - Computed Tomograhy Status NOT_YET_RECRUITING Phase NA
NCT06714383 Trilaciclib Combing Chemotherapy in the Neoadjuvant Treatment of Osteosarcoma Status RECRUITING Phase PHASE2
NCT06709495 Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas Status RECRUITING Phase PHASE1/PHASE2
NCT06699576 ARTEMIS-103: Phase 1b Study of HS-20093 Combinations in Patients with Bone and Soft Tissue Sarcoma. Status NOT_YET_RECRUITING Phase PHASE1
NCT06650514 A Phase 2 Pilot Study to Evaluate the Safety and the Anti-Tumour Activity of the Myc Inhibitor OMO-103 Administered Intravenously in Patients With Advanced High-Grade Osteosarcoma Status RECRUITING Phase PHASE2